Business

DPI developer TFF Pharmaceuticals has received a communication from the European Patent Office (EPO) in regards to its patent application No. 08771657.7 “Formation of Stable Submicron Peptide or Protein Particles by Thin Film Freezing,” giving notice of the EPO's intention to grant a patent. TFF Pharmaceuticals CEO Glenn Mattes commented, “We are very pleased to … [Read more...] about TFF Pharmaceuticals gets European patent for particle technology

Dance Biopharm announced that the company completed a private equity financing round that raised $24.5 million that included participation by Molex Ventures, an electronics company that is involved in development of the Dance 501 connected soft mist inhaler for delivery of insulin. In December 2017, Dance announced that it had partnered with Phillips-Medisize for … [Read more...] about Dance Biopharm raises $24.5 million for continued development of inhaled insulin

VistaGen Therapeutics has acquired exclusive global rights to PH94B aloradine nasal spray, which Pherin Pharmaceuticals has been developing for the treatment of social anxiety disorder (SAD), the company said. A Phase 3 study of PH94B for SAD is planned for the first half of 2019. Pherin received $2.25 million of unregistered common stock from VistaGen for the … [Read more...] about VistaGen licenses nasal spray for the treatment of social anxiety disorder

Mylan said that the company is paying approximately $463 million to Novartis for worldwide rights to TOBI Podhaler tobramycin DPI and TOBI tobramycin inhalation solution. Approximately $240 million of that amount will be paid in 2018. The company said that its acquisition of the products, which are approved in a number of countries for the treatment of P. … [Read more...] about Mylan acquires TOBI products from Novartis

Vectura has announced that revenues from inhaled drugs rose 7.1% in the first half of 2018, with Flutiform revenues up 3.1% compared to the first half of 2017 and up 6.1% compared to the second half of 2017. Total revenue for the six months was up 1.4%. The company also said that results from Phase 2 studies of VR647 nebulized budesonide inhalation suspension … [Read more...] about Vectura inhaled product revenues up more than 7% in first half of 2018

According to Mundipharma, Napp Pharmaceuticals has launched the company's Flutiform fluticasone propionate/formoterol fumarate k-haler breath-activated MDI in the UK. The launch is the first in Europe since Flutiform k-haler was approved for the treatment of asthma in patients aged 12 and older through the decentralized procedure in October 2017. Mundipharma … [Read more...] about Napp Pharmaceuticals launches Mundipharma’s Flutiform k-haler in the UK

Consort Medical subsidiaries Aesica and Bespak will manufacture Opiant Pharmaceuticals' OPNT003 nalmefene nasal spray, the companies said. Earlier this year, Opiant announced that it would develop OPNT003 for the treatment of opioid overdose using the 505(b)(2) pathway, and the company has been awarded a grant worth around $7.4 million by the National Institutes … [Read more...] about Consort Medical to manufacture Opiant’s nalmefene nasal spray

Roivant Sciences has acquired global rights to Patara Pharma's PA101 cromolyn sodium inhalation solution for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), the company said. The inhalation solution, which will now be called RVT-1601, is delivered via the PARI eFlow nebulizer. In 2016, Patara announced positive results from a … [Read more...] about Roivant acquires global rights to Patara’s inhaled cromolyn sodium

United Therapeutics will pay MannKind Corporation $45 million up front and up to $50 million in milestone payments, plus potential double-digit royalties for a worldwide exclusive licensing and collaboration agreement for development and commercialization of a treprostinil DPI for the treatment of pulmonary arterial hypertension (PAH), the companies said. In June … [Read more...] about United Therapeutics and MannKind partner for development of treprostinil DPI for PAH